Australia has approved a world-first koala chlamydia vaccine, offering hope for the endangered marsupial. Developed after over a decade of research, the single-dose vaccine has shown to reduce chlamydia symptoms and mortality by at least 65%. While celebrated by some, conservationists emphasize the need to prioritize habitat preservation, arguing vaccination alone won't solve the koala's broader survival challenges stemming from habitat loss and other threats. The vaccine's approval allows its use in wildlife hospitals and the field to protect at-risk populations.

Prepared by Olivia Bennett and reviewed by editorial team.